Patent Assignment
Reel/Frame 056696/0043
Corrective Assignment to Correct the Assignor's Name Previously Recorded at Reel: 056562 Frame: 0636. Assignor(S) Hereby Confirms the Assignment .
Recorded: 2021-06-28
Pages: 12
Assignor
VIROPHARMA HOLDINGS LIMITED
Executed: 2017-09-28
Assignee
SHIRE VIROPHARMA INCORPORATED
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Methods of Treating Antibody-Mediated Rejection in Organ Transplant Patients with C1-Esterase Inhibitor
Application:
16/983,998 →
Publication:
US 2020/0360495
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 20, 2021
From: SHIRE VIROPHARMA LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056307/0254 →
Assignment of Assignor's Interest
Jun 16, 2021
From: BROOM, COLIN; UKNIS, MARK E.
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 056562/0494 →
Assignment of Assignor's Interest
Jun 16, 2021
From: UKNIS, MARC E.
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 056562/0532 →
Assignment of Assignor's Interest
Jun 16, 2021
From: VIRPHARMA HOLDINGS LIMITED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 056562/0636 →
Change of Name
Jun 16, 2021
From: SHIRE VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA LLC
Reel/Frame 056601/0561 →